| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.0071 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.002 | 1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |